SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-24-000032
Filing Date
2024-03-18
Accepted
2024-03-18 07:04:26
Documents
15
Period of Report
2024-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20240313.htm   iXBRL 8-K 31162
2 EX-10.1 philipgregory_releaseandeq.htm EX-10.1 35233
3 EX-99.1 tsvtodacpressrelease315fin.htm EX-99.1 61603
  Complete submission text file 0001860782-24-000032.txt   282050

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20240313.xsd EX-101.SCH 2010
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20240313_lab.xml EX-101.LAB 23433
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20240313_pre.xml EX-101.PRE 13679
18 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20240313_htm.xml XML 2808
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 24756895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)